« Back to Record
Citation APA

De Cock, E., Hutton, J., Canney, P., Body, J.-J., Barrett-Lee, P., Neary, M., & Lewis, G. (2005). Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. Clinical therapeutics, 27(8), 1295-1310. doi:10.1016/j.clinthera.2005.08.006


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83373

De Cock, E., Hutton, J., Canney, P., Body, J.-J., Barrett-Lee, P., Neary, M., & Lewis, G. (2005). Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom. Clinical therapeutics, 27(8), 1295-1310. doi:10.1016/j.clinthera.2005.08.006